Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Assembly Biosciences, Inc. (ASMB) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$42.47M |
|
$22.09M |
|
-- |
|
$42.47M |
|
$22.67M |
|
$19.80M |
|
$2.29M |
|
$22.09M |
|
$22.09M |
|
$22.09M |
|
$22.09M |
|
$22.09M |
|
$22.09M |
|
$19.80M |
|
$19.00M |
|
11.21M |
|
11.21M |
|
$2.67 |
|
$2.67 |
|
| Balance Sheet Financials | |
$254.55M |
|
$0.22M |
|
$3.04M |
|
$257.59M |
|
$48.78M |
|
-- |
|
$2.06M |
|
$50.84M |
|
$206.75M |
|
$206.75M |
|
$206.75M |
|
15.86M |
|
| Cash Flow Statement Financials | |
$-41.09M |
|
$-113.47M |
|
$174.67M |
|
$38.34M |
|
$58.45M |
|
$20.11M |
|
$4.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.22 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
100.00% |
|
46.62% |
|
46.62% |
|
-- |
|
52.01% |
|
52.01% |
|
$-41.16M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
-- |
|
43.60 |
|
2.06 |
|
10.68% |
|
10.68% |
|
8.58% |
|
10.68% |
|
$13.04 |
|
$-3.67 |
|
$-3.67 |
|